The Successful Oncotarget Journal

Oncotarget was founded in 2010 and it has been one of the best peer-reviewed journals all over the earth that publishes articles on oncology and other topics as well. Its popularity has grown widely since then due to its marvellous and educative publications that cover extensive researches on pharmacology, neuroscience, and cardiology as well as cell biology.

As proven by Thompson Reuters, its Impact Factor globally, increased to 5.168 with its citations increasing from 493 to 10,452 all these between the years 2011 and 2016/17. It is published in English and currently doing so twice every week due to an increase in demand for information. It has over one hundred different editors with members who are specialists in every other field they publish about. Follow Oncotarget on Linkedin.

In one of its articles written by over four authors, it covers the resistance of Insulin as a common molecular dominator that links obesity to the Alzheimer’s disease. It says that the AD is an aging-related and multi-factorial disorder whose metabolic factors lead to a centrally mediated process. It further says that obesity is a recognized factor that leads to AD although the underlying mechanisms maybe unknown. They also provide evidence AD and obesity are involved with oxidative stress, inflammation and or mechanisms that lead to neurodegeneration. You can always visit research gate to learn more about the journal as well as read any of their articles that you would like to know more about.

Oncotarget delivers accurate, insightful as well as on time reviews which helps various scientific researchers, students, medical practitioners and many other personnel to gain knowledge on the medical life as well as new researches and advancements in medicine. It also talks about cancer to help create public awareness with the main aim of the journal being to make the world a better and healthier living place by helping in realisation of new vaccines and cures. Visit Oncotarget’s profile page at facebook.com

Fortunately, oncotarget is an open access journal and I have read through some of its interesting facts such that even if you are not a professional in medicine, you can always benefit in gaining knowledge towards a better living. It covers numerous disciplines as well hence you can never lack something that will interest you. It also accepts articles from various parts of the world.

Read: http://markets.businessinsider.com/news/stocks/Oncotarget-Now-Publishing-Two-Issues-a-Week-Available-in-PubMed-and-Other-High-Profile-Scientific-Research-Indexes-and-Archives-1002382405